1. Home
  2. POLA vs LGVN Comparison

POLA vs LGVN Comparison

Compare POLA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$2.27

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.60

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
LGVN
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
17.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
POLA
LGVN
Price
$2.27
$0.60
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.50
AVG Volume (30 Days)
21.5K
408.1K
Earning Date
11-19-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,326,000.00
$1,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$0.58
52 Week High
$5.75
$2.24

Technical Indicators

Market Signals
Indicator
POLA
LGVN
Relative Strength Index (RSI) 35.74 39.34
Support Level $2.15 $0.58
Resistance Level $2.35 $0.65
Average True Range (ATR) 0.13 0.04
MACD 0.04 0.01
Stochastic Oscillator 37.14 26.77

Price Performance

Historical Comparison
POLA
LGVN

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: